TABLE 1

The prevalence of GADA, IA-2A, and insulin autoantibodies (IAA) in 106 children with Down’s syndrome and 2,860 healthy schoolchildren

Down’s syndrome childrenHealthy schoolchildren
n1062,860
No markers90 (84.9)2,667 (93.3)
Single marker
    GADA2 (1.9)59 (2.0)
    IA-2A3 (2.8)60 (2.1)
    islet autoantibody5 (4.7)61 (2.1)
Two markers
    GADA/IA-2A2 (1.9)2 (0.07)
    GADA/IAA4 (3.8)4 (0.14)
    IA-2A/IAA02 (0.07)
Three markers05 (0.17)
  • Data are n (%).